RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > 2022 > 5 > 500+ gather in Amsterdam for Euro Convergence, RAPS’ largest-ever European event

500+ gather in Amsterdam for Euro Convergence, RAPS’ largest-ever European event

Posted 12 May 2022 | By Zachary Brousseau 

500+ gather in Amsterdam for Euro Convergence, RAPS’ largest-ever European event

RAPS today wrapped up the final day of Euro Convergence 2022, which took place live and in-person in Amsterdam after being held virtually the previous two years. Euro Convergence is the premier annual event for European regulatory professionals. This year’s event drew more than 500 participants from six continents and 33 countries.

Attendees gathered for three days of education sessions, expert presentations and panel discussions curated exclusively by European regulatory leaders and focused on the most pressing topics in medical device, IVD and pharmaceutical regulation for the European market. This year’s Euro Convergence also offered the European regulatory community a long-awaited opportunity to once again meet in person to discuss issues, share ideas and network.

“It was great to be able to convene in person again,” said conference committee co-chair, Siegfried Schmitt, vice president, technical, PAREXEL. “The European regulatory community is still navigating extensive changes to EU regulations even as we continue to address urgent pandemic-related healthcare needs. Bringing health authorities, notified bodies and regulated industry together in the same room has been invaluable.”

Euro Convergence 2022 featured more than 50 education sessions and more than 120 expert speakers. Among the presenters were more than 30 representing health authorities—the European Medicines Agency (EMA), the European Commission (EC), Swissmedic, the Austrian Medicines and Medical Devices Agency, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), and the US Food and Drug Administration (FDA)—or notified bodies, such as BSI, TÜV SÜD, Dekra and Kiwa Dare. The agenda also included poster presentations, sponsored sessions and networking events, and several preconference workshops.

For the first time, Euro Convergence delegates cast votes to select the best poster, which was awarded to “Regulatory intelligence, to protect and to serve your medical device strategy in the world” by Raquel Carnero with IQVIA.

“Euro Convergence 2022 has been a huge success,” said conference committee co-chair, Alex Laan, principal medical research manager, NAMSA. “It is remarkable that RAPS has been able to host such a dynamic, substantive and well-run face-to-face event after two years of meeting virtually. The fact that it has been RAPS’ largest-ever European conference is a testament to the vibrance and dedication of the regulatory community.”

Next year’s Euro Convergence is set to return to Amsterdam, 10–12 May. More information and updates on Euro Convergence 2023 will be available in the coming days at www.raps.org/euroconvergence.

 

© 2022 Regulatory Affairs Professionals Society.